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Abstract
Background: Despite treatment recommendations from various organizations, oral rehydration therapy
(ORT) continues to be underused, particularly by physicians in high-income countries. We conducted a
systematic review of randomised controlled trials (RCTs) to compare ORT and intravenous therapy (IVT)
for the treatment of dehydration secondary to acute gastroenteritis in children.
Methods: RCTs were identified through MEDLINE, EMBASE, CENTRAL, authors and references of
included trials, pharmaceutical companies, and relevant organizations. Screening and inclusion were
performed independently by two reviewers in order to identify randomised or quasi-randomised
controlled trials comparing ORT and IVT in children with acute diarrhea and dehydration. Two reviewers
independently assessed study quality using the Jadad scale and allocation concealment. Data were
extracted by one reviewer and checked by a second. The primary outcome measure was failure of
rehydration. We analyzed data using standard meta-analytic techniques.
Results: The quality of the 14 included trials ranged from 0 to 3 (Jadad score); allocation concealment was
unclear in all but one study. Using a random effects model, there was no significant difference in treatment
failures (risk difference [RD] 3%; 95% confidence intervals [CI]: 0, 6). The Mantel-Haenzsel fixed effects
model gave a significant difference between treatment groups (RD 4%; 95% CI: 2, 5) favoring IVT. Based
on the four studies that reported deaths, there were six in the IVT groups and two in ORT. There were
no significant differences in total fluid intake at six and 24 hours, weight gain, duration of diarrhea, or hypo/
hypernatremia. Length of stay was significantly shorter for the ORT group (weighted mean difference
[WMD] -1.2 days; 95% CI: -2.4,-0.02). Phlebitis occurred significantly more often with IVT (number needed
to treat [NNT] 33; 95% CI: 25,100); paralytic ileus occurred more often with ORT (NNT 33; 95% CI:
20,100). These results may not be generalizable to children with persistent vomiting.
Conclusion: There were no clinically important differences between ORT and IVT in terms of efficacy
and safety. For every 25 children (95% CI: 20, 50) treated with ORT, one would fail and require IVT. The
results support existing practice guidelines recommending ORT as the first course of treatment in
appropriate children with dehydration secondary to gastroenteritis.
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Background
Gastroenteritis is characterized by the acute onset of
diarrhea, which may or may not be accompanied by nau-
sea, vomiting, fever, and abdominal pain [1]. It can be
caused by a variety of infectious agents [2]. Worldwide,
12% of deaths among children less than five years of age
are due to diarrhea [3]. Almost 50% of these deaths are
due to dehydration and most involve children less than
one year of age [4].
Widespread use of oral rehydration salt solutions began in
the 1970s as an effective and inexpensive method of treat-
ing mild to moderate dehydration [5]. Despite the success
of oral rehydration therapy (ORT), its proven efficacy [6]
and recommendations for use by various organizations
[1,5], studies show that ORT continues to be underused
globally [7], and specifically by physicians in high-income
countries [8-11]. A recent report showed that ORT is being
delivered to only 20% of the world's children who could
benefit and that widespread use could prevent 15% of
deaths among children under five years [8]. Postulated
reasons for underuse include the fear of inducing iatro-
genic hypernatremia, time requirements, questionable
efficacy in moderate dehydration, and parental preference
[12].
Although intravenous therapy (IVT) is rapid and effective
in promptly reversing hypovolemic shock, it has some dis-
advantages. Since it must be administered in an outpa-
tient or inpatient setting by specially trained staff, it is
expensive both financially and in terms of human
resources. IVT is associated with complications related to
rapid over-correction of electrolyte imbalances [13],
extravasation of infused solutions into surrounding tis-
sues [14], and infection or inflammation [14]. Though
ORT should not be used in cases of paralytic ileus, it can
be used safely in children of all ages, in cases of acidosis,
and in cases of hyponatremic or hypernatremic dehydra-
tion [15]. It is less traumatic to the child [15], simpler to
administer, and can be administered by parents in a vari-
ety of settings including the home [1]. Research has
shown ORT to be less expensive than IVT, and to be asso-
ciated with lower hospital admission rates and shorter
lengths of stay [16,17].
In an earlier meta-analysis, Gavin et al found that failure
of ORT was uncommon and that ORT may be associated
with more favorable outcomes [6]. The review was criti-
cally appraised by the NHS Centre for Reviews and Dis-
semination (CRD) which concluded that the findings
were likely reliable [18]. In addition, we evaluated the
review by applying Oxman and Guyatt's index of the sci-
entific quality of research overviews [19]. Weaknesses
identified were a limited search (English only and all
included studies were from high-income countries) and
lack of assessment and consideration of the validity of the
included studies.
Despite the existing evidence, ORT continues to be under-
used worldwide, and researchers continue to publish
studies comparing ORT and IVT [20]. The purpose of this
review was to update and expand on the work begun by
Gavin et al with increased scope (countries of all income
levels) and comprehensiveness (language of publication).
Our aim was to conduct a systematic review according to
rigorous methodological standards in order to synthesize
the available evidence comparing ORT to IVT in the treat-
ment of dehydration secondary to acute gastroenteritis in
children. A secondary objective was to evaluate whether
further research, comparing ORT and IVT, is warranted.
This review has been registered with the Cochrane Collab-
oration; regular updates will be available in the Cochrane
Library.
Methods
We searched CENTRAL (Issue 2, 2003), EMBASE (1988–
2003), and MEDLINE (1966–July 2003). The complete
search strategies are presented in an additional file (See
Additional File 1: search_strategies.pdf). In addition, we
contacted the primary authors of included studies, rele-
vant organizations, and manufacturers of commercial
rehydration solutions for additional trials. Finally, we
examined the reference lists of existing reviews and rele-
vant trials.
Two reviewers (SB, KR, or LH) independently screened the
output from the searches to identify potentially relevant
studies. Two reviewers (KR, DM, or LH) independently
assessed each trial for inclusion using predetermined eli-
gibility criteria. We considered studies for inclusion if they
were randomised or quasi-randomised controlled trials
comparing ORT (administered orally [PO] or via nasogas-
tric tube [NG]) and IVT in children one day to 18 years of
age with acute diarrhea and dehydration. Studies that
included malnourished children were considered. We
excluded studies that evaluated populations with cholera.
We did not restrict inclusion by language of publication,
country of study, or publication status.
Two reviewers (SB, WC or KR, LH) independently assessed
study quality. We evaluated studies using the validated
Jadad scale that assesses randomisation, double-blinding,
and withdrawals and drop-outs [21]. We assessed alloca-
tion concealment as adequate, inadequate, or unclear
[22]. Assessment was based on information provided in
the published manuscript. We resolved any differences by
consensus.
One reviewer (SB, KR, or LH) extracted data using a stand-
ard data extraction form. A second reviewer (KR or NW)BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/11
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checked data for accuracy and completeness and entered
data into Review Manager 4.1 (Cochrane Collaboration,
2001). We requested additional data from authors as nec-
essary. The primary outcome was failure of rehydration as
defined by the primary studies. Secondary outcomes
included death, weight gain, length of inpatient hospital
stay, incidence of hypernatremia and hyponatremia, dura-
tion of diarrhea, total fluid intake, total sodium intake,
and serum sodium levels. We also collected data on com-
plications and adverse events.
We analyzed data using Review Manager 4.1 (Cochrane
Collaboration, 2001) and Splus 2000 (Insightful Corpo-
ration, 1999). We expressed dichotomous data as a risk
difference. When outcomes were significant, we calcu-
lated the number needed to treat to help clarify the degree
of benefit for the given IVT risk. We calculated IVT risks
using the weights from the appropriate risk difference
meta-analysis. We converted continuous data to a mean
difference and calculated an overall weighted mean differ-
ence. One study [23] stratified their data by the two sites
(USA and Panama); these were weighted separately in the
analysis and considered as two studies in the tables. We
analyzed the results using a random effects model. The
Chi-square test for heterogeneity [24] was assessed at P =
0.10. We explored possible sources of heterogeneity by
subgroup and sensitivity analyses on the primary out-
come using meta-regression in Stata 7.0 (Stata Corpora-
tion, 2001). These included: inpatient/outpatient status,
patient age, state of nourishment, extent of dehydration,
country's income status, Jadad score, allocation conceal-
ment, and funding support. The relationship between the
osmolarity of the ORT solution and failure to rehydrate
was explored post hoc using a Chi-square subgroup test
[25]. Osmolarity was calculated based on the reported
constituent concentrations in the solutions (see Addi-
tional File 2: ORS compositions). We also examined the
choice of model for sensitivity to the results. We per-
formed intention-to-treat and per protocol analyses. In
addition, we created a more homogeneous failure defini-
tion post hoc and applied it to each article in order to
check the robustness of the per protocol failure results. We
identified and explored all statistical outliers.
We assessed publication bias visually using a funnel plot
and quantitatively using the adjusted rank correlation test
[26], the regression asymmetry test [27], and the trim and
fill method [28] using Stata 7.0.
Results
Trial flow
Figure 1 presents a flow diagram of studies considered for
inclusion in the review. 14 studies met the inclusion crite-
ria [16,17,23,29-39]; one study stratified their data by two
Flow diagram of studies considered for inclusion in the review Figure 1
Flow diagram of studies considered for inclusion in the review. RCT, randomised controlled trial; IVT, intravenous 
therapy; ORT, oral rehydration therapy.
RCTs excluded (n=0)
Studies excluded: not RCT (n=16),
no IVT or ORT arm (n=5), chronic
diarrhea (n=2)
Studies excluded: not RCT or not 
relevant to study question (n=381)
RCTs included in the systematic
review (n=14)
Potentially appropriate RCTs to 
be included in the systematic
review (n=14)
Studies retrieved for detailed
inclusion/exclusion (n=37)
Potentially eligible studies 
identified and screened (n=418)BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/11
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sites (USA and Panama) and we treated this as two studies
in the quantitative analysis [23].
Study characteristics
Tables 1 and 2 describe the included studies (See Addi-
tional files 3 and 4, respectively). The average quality
score was 2; allocation concealment was adequate in one
study [39] and unclear in the others. Six studies received
funding/sponsorship from the pharmaceutical industry
[16,17,23,29,32,38]. One study received funding from
other external sources [23]. Source of funding was not
mentioned in the published version of the remaining
studies. Though three studies [33,36,38] had incomplete
follow up and one other [32] counted a withdrawal as a
failure, none of the studies reported doing an intention-
to-treat (ITT) analysis.
Treatment failure
Based on a random effects (RE) model, there was no sig-
nificant difference in failure to rehydrate (risk difference
[RD] 3%; 95% CI: 0, 6; Table 3 [Additional File 5], Figure
2). The ORT failure risk was 4.6%; the IVT failure risk was
0.7%. The results for failure to rehydrate were sensitive to
the choice of model. The fixed effects Mantel-Haenszel
(FE-MH) model showed a significant risk difference in
failure rate between treatment groups (RD 4%; 95% CI: 2,
5), favoring the IVT group (Table 3 [Additional File 5],
Figure 2). Fixed effects inverse-variance method did not
give a significant result.
One study was a statistical outlier because its risk differ-
ence, given its sample size, was large (RD 13%; 95% CI: 6,
20; n = 200; Figure 2) [31]. Removing this study shifted
the overall risk difference closer to the null (FE-MH RD
2%, 95% CI: 0.2, 4; NNT [number needed to treat] 50,
95% CI: 25, 1000). The heterogeneity in this model was
reduced (P<0.001 vs. P = 0.213).
The definition of "failure" varied by study. We evaluated
the sensitivity of a more homogeneous definition. We
limited failures to the following: children with persistent
vomiting; having some level of dehydration persisting;
and experiencing shock or seizures. Children with para-
lytic ileus, intussusception, cerebral palsy, septicemia, uri-
nary tract infection, and duodenal ulcer were excluded
from this analysis. This post hoc failure definition was
insignificant for both RE and MH-FE models (RD 2%;
95% CI: -0.1, 4; Table 3 [Additional File 5], Figure 2) and
the heterogeneity was also reduced (P<0.001 vs. P =
0.108). Subsequently, subjects who had withdrawn or
dropped-out were reclassified as failures, as in an ITT anal-
ysis. The FE-MH estimate for this model did show signifi-
cant differences in failure rate between treatment groups,
favoring the IVT group (RD 3%; 95% CI: 1, 5).
Metagraph for primary outcome (failure to rehydrate) Figure 2
Metagraph for primary outcome (failure to rehydrate). Studies are arranged in order of increasing sample size. ORT-
NG, oral rehydration therapy-nasogastric; IVT, intravenous therapy; RD, risk difference; CI, confidence intervals.
1995 1/12 0/12 0.08(-0.12,0.29)   Gremse
1986 2/15 0/14 0.13(-0.07,0.33)   Listernick
1990 0/17 0/14 0(-0.12,0.12)   de Pumarejo
2002 3/18 0/16 0.17(-0.03,0.36)   Atherly-John
1987 2/22 0/15 0.09(-0.06,0.24)   Vesikari
1993 4/22 4/18 -0.04(-0.29,0.21)   Issenman
1982b 1/35 1/17 0.03(-0.07,0.13)   Santosham
1994 0/41 0/20 0(-0.07,0.07)   El Mougi
2002 1/47 2/46 -0.02(-0.09,0.05)   Nager
1982a 0/63 0/31 0(-0.05,0.05)   Santosham
1982 0/50 0/50 0(-0.04,0.04)   Singh
1985 3/47 0/50 0.06(-0.01,0.14)   Tamer
1991 2/52 0/52 0.04(-0.02,0.1)   Mackenzie
1988 13/100 0/100 0.13(0.06,0.2)   Gonzalez-Adrino
1985 1/236 0/234 0(-0.01,0.02)   Sharifi
0.03(0,0.06)   Random Effects
0.04(0.02,0.05)   Fixed Effects
0.02(0,0.04)   Post Hoc Fixed Effects
Study Year ORT-NG IVT
n/N n/N
RD (95% CI)
-0.3 -0.2 -0.1 0.0 0.1 0.2 0.3 0.4
-0.3 -0.2 -0.1 0.0 0.1 0.2 0.3 0.4
Random effects
Fixed effects
Post hoc fixed  effects
Favors ORT-NGBMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/11
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Deaths
Three studies reported deaths and supplemental data were
obtained from a fourth author [33]. Singh reported that
all patients were successfully rehydrated, however one
patient succumbed to a "severe pyrogenic reaction" [35].
El-Mougi reported one death in the IVT group due to
pneumonia and ileus [30]. Sharifi reported seven deaths:
two in the ORT group and five in the IVT group [34]. The
cause of death was not reported although four of the seven
deaths occurred in patients below the third percentile
weight class. Mackenzie reported no deaths [33]. All
reported deaths occurred in low-middle income countries
[40].
Other outcomes, complications, and adverse events
There were no differences between ORT and IVT for all
secondary outcomes except length of stay and the occur-
rence of ileus and phlebitis (Table 3 [Additional File 5]).
The ORT group had a shorter length of stay (WMD -1.2
days; 95% CI: -2.4, -0.02) although when the statistical
outlier [31] was excluded, the result was no longer signif-
icant (WMD -0.3 days; 95% CI: -0.8, 0.08).
Since the individual study results were homogeneous for
all complications and adverse events, these were assessed
using the fixed effects model. There was insufficient data
available to generate an adequate analysis of sodium
levels.
Subgroup and sensitivity analyses
Patient status (inpatient vs. outpatient), state of nourish-
ment (well nourished vs. some malnourished), country's
income (low-middle vs. high) [40], funding source
(funded vs. not reported), allocation concealment (ade-
quate vs. unclear), and Jadad scores were explored in meta-
regression using failure to rehydrate as the dependent vari-
able. All were found to be insignificant although the evi-
dence for country's income was close to significance (P =
0.091); treatment differences in low-middle income coun-
tries may be smaller. The remaining a priori subgroup com-
parison results were not reported by subgroup (age, extent
of dehydration) and could not be analyzed. Since the con-
stant variance assumption was not met, we did not explore
the post hoc osmolarity subgroups with meta-regression.
Instead, we divided the trials into low osmolarity (range
208 to 270 mOsmol/L) and high osmolarity (range 299 to
331 mOsmol/L) subgroups; these cut-offs were similar to
those used by Hahn et al [41]. The difference found by
Deek's Chi-square subgroup test [25] was significant
(P<0.0001) and favored the low osmolarity group. The RD
for the low osmolarity group was 1% (95% CI: -1, 2) and it
was homogeneous (P = 0.82); for the high osmolarity
group, the RD was 4% (95% CI: 0, 8) and heterogeneous (P
= 0.04). One study was found to be influential [31]; the
one study that was quasi-randomised was not influential
[35].
Post-hoc subgroup analyses examined exclusion of per-
sistent vomiters as well as ORT route (NG vs. PO vs. a
combination). Neither analysis showed significant
differences.
Publication bias
The regression asymmetry test suggested publication bias
(P = 0.05, bias = 0.84); the adjusted rank correlation test
was not significant (P = 0.11, r = 33). The trim and fill
method indicated two missing studies; the adjusted over-
all effect size was not reduced. The funnel plot appears
somewhat asymmetrical (Figure 3). A small amount of
publication bias may be present suggesting that missing
studies are more likely to favor ORT.
Discussion
The most conservative model showed no important clini-
cal differences between ORT and IVT in terms of safety
and efficacy. For every 25 children treated with ORT, one
would fail and require IVT. The results were consistent
among different populations (e.g. state of nourishment)
but further analyses are required for countries with differ-
ent income levels. These results support existing practice
guidelines recommending ORT as the first course of treat-
ment in children with dehydration secondary to gastroen-
teritis. A cumulative metagraph (Figure 4), which adds
studies by ascending year, shows that the overall estimate
is unlikely to change substantially with further trials.
Overall, more than 1400 children were studied providing
adequate power to support the observed results.
Funnel plot based on primary outcome (failure to rehydrate) Figure 3
Funnel plot based on primary outcome (failure to 
rehydrate). SE, standard error; RD, risk difference.
Risk differenceBMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/11
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The median quality score according to the Jadad scale was
two. Because it is impossible to double-blind studies on
this topic, the quality of studies was limited to a maxi-
mum of three (rather than five). Therefore within this
therapeutic approach, the studies represented reasonable
quality. However it is important to note that studies that
are not double blind can lead to an overestimate of the
treatment effect [42] and that this is an inherent limita-
tion in this literature. While double-blinding is probably
not feasible in a trial comparing IVT and ORT, allocation
can always be properly concealed. Allocation conceal-
ment was unclear in all but one study; this can lead to an
overestimate of treatment effects by as much as 40% [22].
These factors could skew the results in favor of either ORT
or IVT depending on the biases of the investigators.
In applying the evidence to clinical practice, the objective
output of the meta-analysis must be weighed with other
less easily measured factors that support the use of ORT.
These include the amount of discomfort experienced by
the child, the difference in treatment costs, and the
amount of time and labor required to administer ORT.
ORT is less invasive than IVT even when administered via
NG [38]. ORT is less costly than IVT and can be adminis-
tered as rapidly as IVT [38]. In addition, it can be admin-
istered by the child's caregiver and in a setting outside of
the hospital. A recent RCT demonstrated that the use of
ORT in a high-income country pediatric emergency
department resulted in significantly lower costs, less time
spent in the emergency department, and a more favorable
impression of caregivers for this form of therapy [39].
Though there was no statistical heterogeneity between
studies when the one outlying study [31] was omitted,
there were important clinical variations. Rehydration was
accomplished at different rates, by different routes, and
with various solutions in different populations (Table 2
[Additional File 4] and Additional File 2). Comparisons of
different oral rehydration solutions have been the subject
of other reviews [41,43]. A meta-analysis comparing
reduced osmolarity oral rehydration solution (<270 mOs-
mol/l) with the standard solution (311 mOsmol/l)
showed unscheduled intravenous infusion was signifi-
cantly less in the reduced osmolarity group (odds ratio
Cumulative meta-graph of studies comparing ORT versus IVT from 1982–2002 Figure 4
Cumulative meta-graph of studies comparing ORT versus IVT from 1982–2002. RD, risk difference; CI, confidence 
intervals; ORT-NG, oral rehydration therapy-nasogastric.
1982 100 0(-0.04,0.04)   Singh
1982a 194 0(-0.03,0.03)   Santosham
1982b 246 0(-0.03,0.03)   Santosham
1985 716 0(-0.01,0.02)   Sharifi
1985 813 0(-0.01,0.02)   Tamer
1986 842 0.01(0,0.02)   Listernick
1987 879 0.01(0,0.02)   Vesikari
1990 910 0.01(0,0.02)   de Pumarejo
1991 1014 0.01(0,0.02)   Mackenzie
1993 1054 0.01(0,0.02)   Issenman
1994 1115 0.01(0,0.02)   El-Mougi
1995 1139 0.01(0,0.02)   Gremse
2002 1173 0.01(0,0.02)   Atherly-John
2002 1266 0.01(0,0.02)   Nager
Study Year N
*Gonzalez-Adriano 1998 study omitted
RD (95% CI)
-0.04 -0.02 0.0 0.02 0.04
-0.04 -0.02 0.0 0.02 0.04
Favors ORT-NG BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/11
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0.59; 95% CI: 0.45, 0.79) [41]. The World Health Organ-
ization and UNICEF now recommend the reduced osmo-
larity solution. Our post-hoc analysis comparing low and
high osmolarity solutions supported these findings.
Another source of variation was the definitions of "treat-
ment failure" (Table 3 [Additional File 5]). We examined
the effect of different failure definitions through a post
hoc refined-definition analysis and found that it reduced
heterogeneity and made our most conservative model
insignificant. The ITT version of this model involved re-
classifying seven ORT withdrawals as failures; this model
was significant and favored IVT. If the seven withdrawals
were systematically related to treatment benefit then this
ITT analysis is less biased.
One study had a significantly greater failure rate [31]. The
authors of the study attributed it to the fact that many of
the children who failed were younger than six months of
age. This study was the only one to include neonates. The
authors argue that the burden of illness can be more
severe in younger infants. Our data neither prove nor dis-
prove this statement. When this study was removed from
the analysis, the remaining study results were homogene-
ous and the overall risk difference shifted towards the
null.
These results may not be generalizable to all children with
dehydration secondary to gastroenteritis but only to those
with dehydration secondary to diarrhea. A post-hoc look
at studies with different inclusion criteria suggests that
there may be an important difference in response to ORT
among vomiters and non-vomiters. The risk difference for
studies that excluded persistent vomiters was 1% (95% CI:
-4, 6) compared to 4% (95% CI: -2, 10) in studies that did
not exclude persistent vomiters. The issue of how vomit-
ing affects the efficacy of ORT needs further study. How-
ever, in practice, treatment failure only means than one
switches to IVT.
Conclusions
This meta-analysis clearly demonstrates that further RCTs
for children with dehydration secondary to diarrhea are
not warranted, or indeed, may be unethical to perform.
Future research efforts in this area should focus on meth-
ods to improve the uptake of this effective and efficient
intervention in both low- and high-income countries so
children around the world can benefit from ORT.
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